Adipokine regulation of colon cancer: Adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3

Molecular Carcinogenesis

Volumn 49, Issue 7, 2010, Pages 700-709

  Fenton, Jenifer I ^a,b   Birmingham, Janette M ^a  

^a Department of Food Science and Human Nutrition ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adiponectin; Cancer; Colon; IL 6; MC 38

Indexed keywords

ADIPOCYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 6; LEPTIN; NITRIC OXIDE; SOMATOMEDIN C; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CANCER RISK; CARCINOMA CELL; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; INFLAMMATION; MOUSE; NONHUMAN; OBESITY; PRECANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADIPOKINES; ADIPONECTIN; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LEPTIN; MICE; MICE, INBRED C57BL; OBESITY; STAT3 TRANSCRIPTION FACTOR;

MURINAE;

EID: 77954506093     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20644     Document Type: Article

References (41)

1. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565-574.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591. (Pubitemid 39025053)
3. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: Epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006;17:145-156.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009;15:103-113.
6. MunkholmP. Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:1-5.
7. Atreya R, Neurath MF. Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 2008;9:369-374.
8. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: "Cause or effect?" Curr Diabetes Rev 2006;2:195-211.
9. Ealey KN, Archer MC. Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int J Cancer 2009;124:2226-2230.
10. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 2008;116:S4-S6.
11. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704.
12. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes Res 2004;12:962-971.
13. Stattin P, Lukanova A, Biessy C, et al. Obesity and colon cancer: Does leptin provide a link? Int J Cancer 2004;109:149-152.
14. Sweeney G. Leptin signalling. Cell Signal 2002;14:655-663.
15. Li L, Gao Y, Zhang LL, He DL. Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptinmediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biol Ther 2008;7:1787-1792.
16. Perera C, Chin H, Duru N, Camarillo I. Leptin regulated gene expression in MCF-7 breast cancer cells: Mechanistic insights into leptin regulated mammary tumor growth and progression. J Endocrinol 2008;199:221-233.
17. Miyazaki T, Bub JD, Iwamoto Y. c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt. Biochim Biophys Acta 2008;1782:593-604.
18. Ogunwobi OO, Beales IL. Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells. Dig Dis Sci 2007;52: 1934-1945.
19. Sugiyama M, Takahashi H, Hosono K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/ mTOR pathway. Int J Oncol 2009;34:339-344.
20. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-451.
21. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008;285:43-50.
22. Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009;15:79-80.
23. Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc 2008;67:128-145.
24. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
25. Brown KA, Back SJ, Ruchelli ED, et al. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. Am J Gastroenterol 2002;97:2603-2608.
26. Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Increased expression of IL-16 in inflammatory bowel disease. Gut 2001;48:326-332. (Pubitemid 32269559)
27. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 2000;151:31-38.
28. Culig Z, Steiner H, Bartsch G, Hobisch A. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 2005;95:497-505.
29. Huang SP, Wu MS, Shun CT, et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 2004;11:517-527.
30. Fenton JI, Hord NG, Lavigne JA, Perkins SN, Hursting SD. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev 2005;14:1646-1652.
31. Fenton JI, Hursting SD, Perkins SN, Hord NG. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line. Carcinogenesis 2006;27:1507-1515.
32. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI. Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 2009;30:690-697.
33. Corbett TH, Griswold DP, Jr., Roberts BJ, Peckham JC, Schabel FM, Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 1975;35:2434-2439.
34. Pajtasz-Piasecka E, Szyda A, Rossowska J, et al. Loss of tumorigenicity of murine colon carcinoma MC38/0 cell line after transduction with a retroviral vector carrying murine IL-12 genes. Folia Biol (Praha) 2004;50:7-14.
35. Sogn JA, Anton-Culver H, Singer DS. Meeting report: NCI think tanks in cancer biology. Cancer Res 2005;65:9117-9120.
36. Hursting SD, Lashinger LM, Wheatley KW,et al. Reducing the weight of cancer: Mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008;22:659-669.
37. Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 2009;10:610-616.
38. Fenton JI, Birmingham JM, Hursting SD, Hord NG. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+colon epithelial cells. Int J Cancer 2008;122:2437-2445.
39. Nishihara T, Matsuda M, Araki H, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 2006;131:853-861.
40. Fayad R, Pini M, Sennello JA, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007;132:601-614.
41. Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-Mediated Stat3 activation in enterocytes regulates cell survival and cellcycle progression during colitis-associated tumorigenesis. Cancer Cell 2009;15:91-102.